Clin2
NCT05713877Possibly a fitRecruiting

Melatonin to treat confusion in ICU patients

Delirium

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This Phase 2 trial tests whether melatonin can reduce delirium, a sudden confusion that can happen in the ICU. If you qualify, you may be given melatonin to see if it improves alertness and comfort during an expected longer ICU stay.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older and admitted to the intensive care unit (ICU)
  • Your care team expects you will stay in the ICU for more than 48 hours
  • You have signs of ICU delirium, with an ICDSC score of 4 or higher within the last 48 hours
  • You have not taken melatonin in the past 24 hours
  • You do not have allergy or known sensitivity to melatonin or the study medicine ingredients
  • You are not pregnant or breastfeeding, and you can use enteral medicines (through a tube or by mouth)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06509191Recruiting· Phase 2/Phase 3
Melatonin for preventing delirium in older hospital patients

This trial tests if giving melatonin (a natural sleep hormone) can help prevent delirium (sudden confusion) in older adults who are hospitalized. It may help you if you are 65 or older and admitted to the hospital for general medical care.

Muscat
NCT05069428Recruiting· Phase 4
Ramelteon to reduce confusion in ICU patients

This trial tests whether ramelteon, a sleep medicine, can reduce delirium—a sudden confusion problem—in people in the intensive care unit (ICU). If you qualify, it may help you (or your loved one) stay clearer and more comfortable during ICU treatment.

Nashville, Tennessee
NCT07407400Not yet recruiting· Phase 4
Lemborexant for sleep and delirium prevention in elderly ICU patients

This trial tests whether the sleep medication lemborexant can help prevent delirium and improve sleep in elderly patients staying in the surgical ICU. If you qualify, you would receive the study drug or a placebo to see if it helps you stay more alert and avoid confusion during your ICU stay.

NCT06824077Not yet recruiting· Early Phase 1
Sleep study to reduce delirium in the ICU

This study tests if adding a calming medicine called dexmedetomidine to a sleep-promoting routine can help reduce delirium in ICU patients who are awake and on a breathing machine or high-flow oxygen.

NCT06294158Recruiting
Light and noise in the ICU and delirium risk

This study looks at how light and noise in the intensive care unit (ICU) might affect confusion and disorientation (delirium). By tracking these environmental factors, researchers hope to find ways to reduce delirium for ICU patients.

Graz, Styria
NCT07369258Recruiting
Music to prevent confusion in the ICU for older adults

This trial tests whether listening to music can help prevent delirium (sudden confusion) in older patients in the intensive care unit. If it works, it could offer a simple, drug-free way to protect your thinking during a hospital stay.

Buenos Aires, Buenos Aires F.D.

Hear when a new Delirium trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.